27
Participants
Start Date
December 27, 2021
Primary Completion Date
March 21, 2028
Study Completion Date
March 21, 2028
crizotinib
crizotinib oral treatment
National Taiwan University Hospital, Taipei
ASST Monza, Monza
Cancer Hospital Chinese Academy of Medical Science, Beijing
Beijing Cancer Hospital, Beijing
Jilin Cancer Hospital, Changchun
"Limited Liability Company EuroCityClinic", Saint Petersburg
Shanghai Chest Hospital, Shanghai
The First Affiliated Hospital of College of Medicine,Zhejiang University, Hangzhou
Fujian Province Oncology Hospital, Fuzhou
Sun Yat-Sen University Cancer center, Guangzhou
The First Affiliated Hospital of Guangzhou Medical University., Guangzhou
West China Hospital of Sichuan University, Wuhou District
National Hospital Organization Nagoya Medical Center, Nagoya
Lead Sponsor
Pfizer
INDUSTRY